FDA Issues Safety Alert Against Ovarian Cancer Screening Tests

FDA Issues Safety Alert Against Ovarian Cancer Screening Tests
The U.S. Food and Drug Administration (FDA) is alerting women and their clinicians about tests that are marketed to detect ovarian cancer. The FDA is particularly concerned that inaccurate results of these tests will delay the administration of preventive treatments for women at risk for developing ovarian cancer. “Despite extensive research and published studies, there are currently

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

Leave a Comment

Your email address will not be published. Required fields are marked *